استمتع بـUnlimited مع Magzter GOLD

استمتع بـUnlimited مع Magzter GOLD

احصل على وصول غير محدود إلى أكثر من 9000 مجلة وصحيفة وقصة مميزة مقابل

$149.99
 
$74.99/سنة

يحاول ذهب - حر

Prosus eyes biggest bite of Swiggy’s Rapido stake

September 16, 2025

|

Mint Mumbai

Deal may value Rapido at up to $2.7 bn; Nexus, WestBridge too want to raise stakes

- Sakshi Sadashiv & Sneha Shah

Dutch technology investor Prosus NV is looking to snap up the largest piece of Swiggy’s stake in Rapido, three people familiar with the matter said, in a deal that could value the ride-hailing startup at as much as $2.7 billion.

Prosus is looking to invest $150-180 million for a significant portion of the roughly 12% stake that Swiggy holds in Rapido, one of the three people said on the condition of anonymity. Meanwhile, Rapido’s existing investors Nexus Venture Partners and WestBridge Capital are also seeking to increase their holdings.

Rapido was last valued at $1.1 billion in September 2024, when it secured $200 million in its Series E fundraising round led by West-Bridge Capital. If Swiggy sale indeed values Rapido at $2.7 billion, the 12% stake would be worth a little over $320 million, or 2,825 crore.

Swiggy, which had acquired the Rapido stake in April 2022 for $180 million, informed shareholders in July that it would reevaluate the investment after the mobility startup decided to enter Swiggy’s stronghold of food delivery.

As of June, Prosus owned about 2.7% in Rapido, while Nexus and WestBridge owned 9.9% and 19%, respectively, show data accessed by Tracxn. Rapido founders Pavan Guntupalli and Aravind Sanka own 4.8% each, while Rishikesh S.R., another co-founder, owns 1.8%.

المزيد من القصص من Mint Mumbai

Mint Mumbai

Mint Mumbai

Gen Alpha will make new rules for their workplace

Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’

time to read

3 mins

December 01, 2025

Mint Mumbai

EC extends electoral roll revision by a week to II Dec; final list on 14 Feb

The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.

time to read

2 mins

December 01, 2025

Mint Mumbai

THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS

These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.

time to read

3 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

Green hydrogen: Fast fashion could help bump up demand

A boom in its use for clean synthetic inputs might make a difference

time to read

3 mins

December 01, 2025

Mint Mumbai

Let's be a bit more selective in using the word 'reforms'

Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.

time to read

3 mins

December 01, 2025

Mint Mumbai

As mid-cap alpha shrinks, should you consider passive strategies?

Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey

time to read

4 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

With $2.2 bn fund, ChrysCap has appetite for riskier bets

MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing

time to read

3 mins

December 01, 2025

Mint Mumbai

GDP growth of 8% plus: How to sustain this pace

Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships

time to read

2 mins

December 01, 2025

Mint Mumbai

INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES

Detection tools today are not universal or consistent across languages

time to read

5 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

APIs to innovation: Bulk drug makers ramp up CDMO bets

Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.

time to read

2 mins

December 01, 2025

Listen

Translate

Share

-
+

Change font size